Current status and perspectives on stem cell-based therapies undergoing clinical trials for regenerative medicine: case studies
BACKGROUND. Apart from haematopoietic stem cell transplantation for haematological disorders many stem cell-based therapies are experimental. However, with only 12 years between human embryonic stem cell isolation and the first clinical trial, development of stem cell products for regenerative medic...
Saved in:
Main Authors: | Elizabeth Ratcliffe, Katie Glen, May W. Naing, David Williams |
---|---|
Format: | Default Article |
Published: |
2013
|
Subjects: | |
Online Access: | https://hdl.handle.net/2134/26156 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chemical biology in regenerative medicine : bridging stem cells and future therapies / edited by Charles C. Hong, Ada S. Ao, and Jijun Hao.
Published: (2014) -
Manufacture of a human mesenchymal stem cell population using an automated cell culture platform
by: Rob Thomas, et al.
Published: (2007) -
Precision manufacturing for clinical-quality regenerative medicines
by: David Williams, et al.
Published: (2012) -
The early career researcher's toolkit: translating tissue engineering, regenerative medicine and cell therapy products
by: Qasim A. Rafiq, et al.
Published: (2015) -
The efficacy of different sources of mesenchymal stem cell for the treatment of osteoarthitis
by: Maryam Shariatzadeh, et al.
Published: (2019)